Scutellarin protects against lipopolysaccharide-induced acute lung injury via inhibition of NF-κB activation in mice

Journal of Asian Natural Products Research

Volumn 12, Issue 3, 2010, Pages 175-184

  Tan, Zheng Huai ^a,b   Yu, Ling Hong ^a   Wei, Huai Ling ^a   Liu, Geng Tao ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b Visiting Scholar from Sichuan Institute   (China)

Author keywords

Acute lung injury; INOS; LPS; NF B; Scutellarin

Indexed keywords

ERIGERON BREVISCAPUS EXTRACT; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FAS LIGAND; GLUTATHIONE; I KAPPA B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; MESSENGER RNA; NITRATE; NITROGEN DIOXIDE; PROTEIN C FOS; PROTEIN C JUN; SCUTELLARIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ERIGERON; GENE EXPRESSION; LUNG LESION; MALE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRACHEOBRONCHIAL TOILET;

ACTINS; ACUTE LUNG INJURY; ANIMALS; APIGENIN; ENDOTOXINS; ESCHERICHIA COLI; GENES, FOS; GLUCURONIC ACIDS; LIPOPOLYSACCHARIDES; LUNG; MICE; MOLECULAR STRUCTURE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

ESCHERICHIA COLI; MUS;

EID: 77951443585     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020903347906     Document Type: Article

References (25)

1. T. Okamoto, K. Gohil, E.I. Finkelstein, P. Bove, T. Akaike, and A. van der Vliet, Am. J. Physiol. Lung Cell Mol. Physiol. 286, L198 (2002).
2. J.D. Lang, P.J. McArdle, P.J. O'Reilly, and S. Matalon, Chest (Review) 122 (6 Suppl.), 314S (2002).
3. W. Droge, Physiol. Rev. 82, 47 (2002).
4. A. Van der Vleit, J.P. Eiserich, and C.E. Cross, Respir. Res. 1, 67 (2000).
5. P.G. Xiao and K.J. Cheng, Phytother. Res. 1, 53 (1987).
6. H. Liu, X.L. Yang, L. Zhou, and H. Xu, J. Chin. Med. Mater. 25, 491 (2002).
7. X.F. Yang, W. He, W.H. Lu, and F.D. Zeng, Acta Pharmacol. Sin. 24, 1118 (2003).
8. A.A. Eltayeb, Q. Liu, L. Gan, H. Liu, and H. Xu, Biol. Trace Elem. Res. 98, 253 (2004).
9. Z.H. Tan, L.H. Yu, H.L. Wei, and G.T. Liu, J. Pharm. Pharmacol. 59, 115 (2007).
10. M. Moss, P.L. Goodman, M. Heining, S. Barkin, L. Ackerson, and P.E. Parsons, Crit. Care Med. 23, 1629 (1995).
11. H. Ito, N. Koide, F. Hassan, S. Islam, G. Tumurkhuu, I. Mori, T. Yoshida, S. Kakumu, H. Moriwaki, and T. Yokochi, Lab. Invest. 86, 254 (2006).
12. R. Witkamp and M. Monshouwer, Vet Q. 22, 11 (2000).
13. H. Glosli, K.J. Tronstag, H. Wergedal, F. Muller, A. Svardal, P. Aukrust, R.K. Berge, and H. Prydz, FASEB J. 16, 1450 (2002).
14. S. Corda, C. Laplace, E. Vicaut, and J. Duranteau, Am. J. Respir. Cell Mol. Biol. 24, 762 (2001).
15. J.P. Mizgerd, M.L. Scott, M.R. Spieker, and C.M. Doerschuk, Am. J. Respir. Cell Mol. Biol. 27, 575 (2002).
16. D.V. Kuprash, I.A. Udalova, R.L. Turetskaya, D. Kwiatkowski, N.R. Rice, and S.A. Nedospasov, J. Immunol. 162, 4045 (1999).
17. L.C. Sambucetti and T. Curran, Science 234, 1417 (1986).
18. M. Renz, B. Verier, C. Kurz, and R. Muller, Nucl. Acids Res. 15, 277 (1987).
19. D. Bohmann, T.J. Bos, A. Admon, T. Nishimura, P.K. Vogt, and R. Tjian, Science 238, 1386 (1987).
20. L.J. Hanson, V. Anest, J. Reuther-Madrid, and S.A. Baldwin, J. Biol. Chem. 278, 34910 (2003).
21. A. Tanaka, M. Konno, S. Muto, N. Kambe, E. Morii, T. Nakahata, A. Itai, and H. Matsuda, Blood 105, 2324 (2005).
22. N. Matsuda, Y. Hattori, S. Jesmin, and S. Gando, Mol. Pharmacol. 67, 1018 (2005).
23. A.F. Boyne and G.L. Ellman, Anal. Biochem. 46, 639 (1972).
24. H. Ohkawa, N. Ohishi, and K. Yagi, Anal. Biochem. 95, 351 (1979).
25. O.H. Lowry, N.J. Rosenbrough, and A.L. Farr, J. Biol. Chem. 193, 65 (1959).